X0306 4 2021-12-29 0 0001610618 Cidara Therapeutics, Inc. CDTX 0001751478 Johnson Brady 6310 NANCY RIDGE DRIVE SAN DIEGO CA 92121 0 1 0 0 Vice President, Finance Common Stock 2021-12-29 4 M 0 262 0.00 A 51381 D Common Stock 2022-01-05 4 S 0 416 1.25 D 50965 D Restricted Stock Unit 2021-12-29 4 M 0 262 0.00 D 2027-09-17 Common Stock 262 262 D The Reporting Person was previously granted restricted stock units to vest upon the achievement of certain milestone events that occurred on December 29, 2021. Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 19, 2021. Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on December 29, 2021 and January 1, 2022. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer. On January 31, 2019, the Reporting Person was granted RSUs totaling 787 shares subject to vesting upon the achievement of various milestones. /s/ Brady Johnson 2022-01-07